Publications by authors named "Dean James"

Claim this Profile
F
Final analysis of the RESONATE-2 study: up to 10 years of follow-up of first-line ibrutinib treatment for CLL/SLL.
Jan A Burger, Paul M Barr, Tadeusz Robak, Carolyn Owen, Alessandra Tedeschi, James P Dean

Blood· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Advantages of FEV Percent Predicted Change During Bronchial Challenge Testing.
James Dean, Augusta Beech, Dave Singh

Lung· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ibrutinib plus venetoclax in relapsed or refractory mantle cell lymphoma (SYMPATICO): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study.
Michael Wang, Wojciech Jurczak, Marek Trneny, David Belada, Tomasz Wrobel, James P Dean

Lancet Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expiratory flow limitation development index (ELDI): a novel method of assessing respiratory mechanics in COPD.
James Dean, Stephen J Fowler, Dave Singh, Augusta Beech

Respir Res· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The scientific rationale and study protocol for the DPP3, Angiotensin II, and Renin Kinetics in Sepsis (DARK-Sepsis) randomized controlled trial: serum biomarkers to predict response to angiotensin II versus standard-of-care vasopressor therapy in the treatment of septic shock.
J Pedro Teixeira, David Perez Ingles, Jordan B Barton, James T Dean, Pablo Garcia

Trials· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
When to Stop Antibiotics in the Critically Ill?
Nathan D Nielsen, James T Dean, Elizabeth A Shald, Andrew Conway Morris, Pedro Povoa

Antibiotics (Basel)· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absence of BTK, BCL2, and PLCG2 Mutations in Chronic Lymphocytic Leukemia Relapsing after First-Line Treatment with Fixed-Duration Ibrutinib plus Venetoclax.
Nitin Jain, Lisa J Croner, John N Allan, Tanya Siddiqi, Alessandra Tedeschi, James P Dean

Clin Cancer Res· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of the Methodology of Specific Airway Resistance Measurements in COPD.
James Dean, Dave Singh

Int J Chron Obstruct Pulmon Dis· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Takotsubo Cardiomyopathy Syndrome in Critical Care Transport: A Case and Critical Review.
Colin Standifird, Sean Kaisler, Adam L Gottula, Michael J Lauria, James T Dean

Air Med J· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ibrutinib combination therapy for advanced gastrointestinal and genitourinary tumours: results from a phase 1b/2 study.
Do-Youn Oh, Maria Alsina Maqueda, David I Quinn, Peter J O'Dwyer, Ian Chau, James P Dean

BMC Cancer· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exhaled nitric oxide, eosinophils and current smoking in COPD patients.
Andrew Higham, Augusta Beech, James Dean, Dave Singh

ERJ Open Res· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune restoration with ibrutinib plus venetoclax in first-line chronic lymphocytic leukemia: the phase 2 CAPTIVATE study.
Carol Moreno, Isabelle G Solman, Constantine S Tam, Andrew Grigg, Lydia Scarfò, James P Dean

Blood Adv· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
B-cell Receptor Pathway Mutations Are Infrequent in Patients with Chronic Lymphocytic Leukemia on Continuous Ibrutinib Therapy.
Jennifer A Woyach, Paolo Ghia, John C Byrd, Inhye E Ahn, Carol Moreno, James P Dean, Danelle F James

Clin Cancer Res· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pediatric Chest Compression Improvement Via Augmented Reality Cardiopulmonary Resuscitation Feedback in Community General Emergency Departments: A Mixed-Methods Simulation-Based Pilot Study.
Keith Kleinman, Tai Hairston, Brittany Smith, Emma Billings, Sean Tackett, James L Dean

J Emerg Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results from a Phase 1b/2 Study of Ibrutinib Combination Therapy in Advanced Urothelial Carcinoma.
Nataliya Mar, Yousef Zakharia, Alejandro Falcon, Rafael Morales-Barrera, Begona Mellado, James P Dean

Cancers (Basel)· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of coronavirus disease 2019 (COVID-19) and risk factors associated with severe COVID-19 in patients with mature B-cell non-Hodgkin lymphomas: A US electronic health record cohort study.
Xiaomeng Yue, David Hallett, Yangyang Liu, Elisa Basa, Annie McNeill, James P Dean

Eur J Haematol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line treatment of chronic lymphocytic leukemia with ibrutinib plus obinutuzumab chlorambucil plus obinutuzumab: final analysis of the randomized, phase III iLLUMINATE trial.
Carol Moreno, Richard Greil, Fatih Demirkan, Alessandra Tedeschi, Bertrand Anz, James P Dean

Haematologica· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paediatric chest compression performance improves via novel augmented-reality cardiopulmonary resuscitation feedback system: A mixed-methods pilot study in a simulation-based setting.
Justin M Jeffers, Blake A Schreurs, James L Dean, Brandon Scott, Therese Canares

Resusc Plus· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fixed-duration ibrutinib plus venetoclax for first-line treatment of CLL: primary analysis of the CAPTIVATE FD cohort.
Constantine S Tam, John N Allan, Tanya Siddiqi, Thomas J Kipps, Ryan Jacobs, James P Dean

Blood· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expiratory flow limitation in a cohort of highly symptomatic COPD patients.
Augusta Beech, Natalie Jackson, James Dean, Dave Singh

ERJ Open Res· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term efficacy of first-line ibrutinib treatment for chronic lymphocytic leukaemia in patients with TP53 aberrations: a pooled analysis from four clinical trials.
John N Allan, Tait Shanafelt, Adrian Wiestner, Carol Moreno, Susan M O'Brien, James P Dean

Br J Haematol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using ibrutinib in earlier lines of treatment results in better outcomes for patients with chronic lymphocytic leukemia/small lymphocytic lymphoma.
Jennifer Woyach, Alessandra Tedeschi, Talha Munir, Tanya Siddiqi, Peter Hillmen, James P Dean

Leuk Lymphoma· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ibrutinib Plus Venetoclax for First-Line Treatment of Chronic Lymphocytic Leukemia: Primary Analysis Results From the Minimal Residual Disease Cohort of the Randomized Phase II CAPTIVATE Study.
William G Wierda, John N Allan, Tanya Siddiqi, Thomas J Kipps, Stephen Opat, James P Dean, Danelle F James

J Clin Oncol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CuZrO: If it exists it should be a sandwich.
James Dean, Yahui Yang, Götz Veser, Giannis Mpourmpakis

Phys Chem Chem Phys· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methacholine challenges: comparison of different tidal breathing challenge methods.
James Dean, Natalie Jackson, Brett Keidel-Morgan, Daniel Hamer, Dave Singh

ERJ Open Res· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis